Clovis Oncology, Inc. Quarterly Return On Equity in % from Q3 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Clovis Oncology, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2012 to Q3 2022.
  • Clovis Oncology, Inc. Return On Equity for the quarter ending September 30, 2022 was 73.7 %, a 50% decline year-over-year.
  • Clovis Oncology, Inc. annual Return On Equity for 2021 was 113 %, a 58% decline from 2020.
  • Clovis Oncology, Inc. annual Return On Equity for 2020 was 270 %, a 63.4% decline from 2019.
  • Clovis Oncology, Inc. annual Return On Equity for 2019 was 739 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 73.7 -73.6 -50% Jul 1, 2022 Sep 30, 2022
Q2 2022 89.6 -75.9 -45.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 102 -108 -51.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 113 -157 -58% Oct 1, 2021 Dec 31, 2021
Q3 2021 147 -116 -44% Jul 1, 2021 Sep 30, 2021
Q2 2021 165 -151 -47.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 210 -185 -46.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 270 -468 -63.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 263 +1.8K Jul 1, 2020 Sep 30, 2020
Q2 2020 317 +690 Apr 1, 2020 Jun 30, 2020
Q1 2020 395 +591 Jan 1, 2020 Mar 31, 2020
Q4 2019 739 +886 Oct 1, 2019 Dec 31, 2019
Q3 2019 -1.54K -1.44K -1366% Jul 1, 2019 Sep 30, 2019
Q2 2019 -373 -282 -311% Apr 1, 2019 Jun 30, 2019
Q1 2019 -196 -85.3 -76.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -147 -30.5 -26% Oct 1, 2018 Dec 31, 2018
Q3 2018 -105 +74.4 +41.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -90.7 +169 +65% Apr 1, 2018 Jun 30, 2018
Q1 2018 -111 +270 +70.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -117 +233 +66.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -180 +46.8 +20.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -259 -96.7 -59.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -381 -251 -193% Jan 1, 2017 Mar 31, 2017
Q4 2016 -350 -229 -190% Oct 1, 2016 Dec 31, 2016
Q3 2016 -226 -130 -135% Jul 1, 2016 Sep 30, 2016
Q2 2016 -163 -84.3 -108% Apr 1, 2016 Jun 30, 2016
Q1 2016 -130 -75.7 -139% Jan 1, 2016 Mar 31, 2016
Q4 2015 -121 -81.8 -209% Oct 1, 2015 Dec 31, 2015
Q3 2015 -96.2 -66.4 -222% Jul 1, 2015 Sep 30, 2015
Q2 2015 -78.2 -52.1 -199% Apr 1, 2015 Jun 30, 2015
Q1 2015 -54.4 -30.7 -130% Jan 1, 2015 Mar 31, 2015
Q4 2014 -39.2 -13.7 -53.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -29.8 +1.93 +6.08% Jul 1, 2014 Sep 30, 2014
Q2 2014 -26.2 +12.5 +32.3% Apr 1, 2014 Jun 30, 2014
Q1 2014 -23.7 +25.4 +51.7% Jan 1, 2014 Mar 31, 2014
Q4 2013 -25.5 +26.4 +50.9% Oct 1, 2013 Dec 31, 2013
Q3 2013 -31.8 +16 +33.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -38.7 Apr 1, 2013 Jun 30, 2013
Q1 2013 -49.1 Jan 1, 2013 Mar 31, 2013
Q4 2012 -51.9 Oct 1, 2012 Dec 31, 2012
Q3 2012 -47.8 Jul 1, 2012 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.